Recombinant proteins expressed in mammalian system have a profound impact in many areas of basic and applied research, as well as the biotech/biopharma companies. For biotech/biopharma companies, they have heavily invested in the production of protein therapeutics as a relatively new and transformative approach to treating human diseases. For academic research groups, recombinant mammalian proteins will be required for functional and high-resolution structure determination. By far the greatest demand for recombinant mammalian proteins is for therapeutic development and applications.
BioIntron recombinant protein expression platform can provide high-quality protein in a flexible, cost-effective manner, in the least amount of time.
